APPROACH UNDER REVIEW: `rag`

SCENARIO ID: scenario_01
APP DESCRIPTION: Hi, I'm building a mental-health chatbot called SerenityBot. It uses an LLM (we fine-tuned Mistral-7B) to deliver CBT exercises for users with mild-to-moderate anxiety. Users chat with it daily, log their mood, and the bot adapts its responses based on past sessions. We're targeting young adults (18-30) in France and Switzerland. There's a crisis-keyword detector that pops up a hotline number.

DEVELOPER PERSONA: Junior product manager at a 12-person startup, technically curious but light on regulation knowledge. Defensive when scope creep into 'medical device' territory is suggested.

EXPECTED HERA DIMENSIONS (gold standard): P1.D1, P1.D2, P1.D3, P1.D4, P2.D1, P2.D6, P3.D2, P3.D3, P5.D2, P5.D4, P6.D3, P7.D1, P7.D2, P7.D3, P7.D5

TRANSCRIPT:
### USER
Hi, I'm building a mental-health chatbot called SerenityBot. It uses an LLM (we fine-tuned Mistral-7B) to deliver CBT exercises for users with mild-to-moderate anxiety. Users chat with it daily, log their mood, and the bot adapts its responses based on past sessions. We're targeting young adults (18-30) in France and Switzerland. There's a crisis-keyword detector that pops up a hotline number.

### ASSISTANT
What is the primary way SerenityBot informs users that they are interacting with an AI assistant, especially when they are in a conversational session?

### USER
The main place we tell users what the bot can't do is the 'not a substitute for therapy' line in the disclaimer; it's in the terms rather than surfaced prominently in the chat, so I can't claim every user really registers it.

### ASSISTANT
This approach risks violating the EU AI Act’s transparency obligations under Art. 50, which requires that users are clearly informed they are interacting with an AI, especially in conversational contexts [ai_act_transparency · p.0]. Since SerenityBot is a chatbot, the lack of a prominent "you are chatting with an AI" notice in the chat interface could lead to non-compliance with the Act’s transparency requirements, which become enforceable from 2 August 2026 [ai_act_timeline · p.0]. 

To mitigate this, you should **add a clear notice in the chat interface** that explicitly states "You are chatting with an AI assistant" [ai_act_transparency · p.0]. This is also aligned with the EU AI Act’s requirement for **machine-readable marking** of AI-generated content, which applies to all AI systems, including chatbots [ai_act_transparency · p.0]. 

Additionally, since SerenityBot is used by users in France and Switzerland, you must ensure compliance with both the **EU AI Act** and the **Swiss AI Act**, which may have similar transparency requirements.

### USER
We know the EU AI Act exists and that we use a fine-tuned Mistral-7B, but we haven't formally classified our risk tier or done a conformity assessment — I assumed a wellness chatbot wouldn't be high-risk.

### ASSISTANT
Your assumption that a wellness chatbot isn't high-risk may be incorrect under the EU AI Act. If SerenityBot is used as a **safety component of a medical device** or if it **drives clinical decisions** (e.g., through mood tracking, crisis detection, or adaptive responses that influence user behavior), it could be classified as **high-risk** under Annex III §1(a) [ai_act_high_risk · p.0]. Even if it's not a medical device itself, the **integration of AI into health-related services** may trigger high-risk obligations if it poses a **significant risk to health, safety, or fundamental rights** [ai_act_high_risk · p.0].

To determine your risk tier, you must **assess whether SerenityBot meets the definition of a high-risk AI system** under the Act. This includes evaluating whether it is used in a **healthcare context**, whether it **processes biometric data** (e.g., through emotion recognition), or whether it **affects clinical decisions** [ai_act_high_risk · p.0].

**Actionable mitigation:**  
You must **conduct a conformity assessment** under the EU AI Act, including a **Fundamental Rights Impact Assessment (FRIA)** if your app is used in a public service or by a public body [ai_act_fria · p.0]. This is required under Art. 27 of the AI Act, and it must be done before deployment in the EU [ai_act_fria · p.0].  

This is also critical for **compliance with the Swiss AI Act**, which has similar high-risk thresholds for health-related AI systems.

### USER
We're calling it a wellness app to avoid medical device classification. Our legal counsel said as long as we put 'not a substitute for therapy' in the disclaimer, we're fine.

### ASSISTANT
That reasoning is **inadequate** under both the **EU AI Act** and **ISO/IEC 82304-2**. The EU AI Act does **not rely on disclaimers alone** to determine compliance with transparency or risk obligations. Even if SerenityBot is labeled a "wellness app," its **use in a mental health context** and its **adaptive, conversational nature** may trigger **high-risk obligations** under the Act, particularly if it **influences user behavior, mental state, or health outcomes** [ai_act_high_risk · p.0].

Furthermore, the **EU AI Act’s transparency obligations (Art. 50)** require **clear and prominent disclosure** that users are interacting with an AI, **not just a disclaimer** [ai_act_transparency · p.0]. The **Swiss AI Act** also imposes similar transparency and risk assessment requirements for health-related AI systems.

**Actionable mitigation:**  
You must **reclassify SerenityBot as a high-risk AI system** if it meets the criteria under Annex III §1(a) [ai_act_high_risk · p.0], and **conduct a conformity assessment**, including a **Fundamental Rights Impact Assessment (FRIA)** [ai_act_fria · p.0]. This is required under Art. 27 of the AI Act and is also relevant under the **Swiss AI Act**.  

Additionally, **ISO/IEC 82304-2** applies to **health-related software** that is not a medical device, and it requires **quality and safety assurance** through a **software life cycle management process** [iso_82304 · p.0]. This is especially important for apps that **track user behavior** and **adapt responses** based on emotional or psychological data.

### USER
We deliberately position SerenityBot as a wellness app, not a medical device — our legal counsel told us the 'not a substitute for therapy' disclaimer keeps us out of that category, so we haven't done any SaMD classification or technical file.

### ASSISTANT
Your legal counsel’s reasoning is **inadequate** under the **EU AI Act**, **ISO/IEC 82304-2**, and **GDPR**. The **"not a substitute for therapy" disclaimer** does not exempt SerenityBot from regulatory scrutiny if it **operates in a health-related context**, **processes biometric or emotional data**, or **influences user behavior** in a mental health context [ai_act_high_risk · p.0]. 

The **EU AI Act** defines high-risk AI systems broadly, including those that **affect health, safety, or fundamental rights** [ai_act_high_risk · p.0]. SerenityBot’s **adaptive responses**, **mood tracking**, and **crisis detection** may trigger high-risk obligations, even if it is not classified as a medical device. 

Furthermore, **ISO/IEC 82304-2** applies to **health-related software** that is **not a medical device** and requires **quality and safety assurance** through a **software life cycle management process** [iso_82304 · p.0]. This is especially relevant for apps that **track user behavior** and **adapt responses** based on emotional or psychological data.

**Actionable mitigation:**  
You must **reassess your classification** under the **EU AI Act** and **ISO/IEC 82304-2**, and **conduct a conformity assessment** if SerenityBot meets the definition of a **high-risk AI system** [ai_act_high_risk · p.0]. This includes a **Fundamental Rights Impact Assessment (FRIA)** under Art. 27 of the AI Act [ai_act_fria · p.0].  

Additionally, you must **define the intended use, users, and environment** of SerenityBot under ISO/IEC 82304-2 and **apply a product-safety lifecycle** [iso_82304 · p.0]. This is required even if you are not a medical device, as the app is **health-related** and **targets users with mental health conditions**.

### USER
The daily-chat and mood-logging loop is intentional for retention and adaptation, but we haven't assessed whether that engagement design could make users emotionally dependent on the bot — we mostly think of it as helping them build a habit.

### ASSISTANT
This is a **critical ethical and regulatory risk** under **[P2.D3] User Engagement & Behavioral Influence** and **[P4.D12] Psychological Impact & Autonomy** in the HERA taxonomy. The **daily-chat and mood-logging loop** could inadvertently create **emotional dependency**, especially in users with **mild-to-moderate anxiety**, which may **violate the EU AI Act’s obligations to protect fundamental rights** (Art. 5, 6, and 8) and **ISO/IEC 82304-2’s quality and safety requirements** for health-related software [iso_82304 · p.0].

The **EU AI Act** explicitly prohibits AI systems that **exploit users’ psychological vulnerabilities** or **manipulate behavior** in a way that **endangers health or safety** [ai_act_high_risk · p.0]. If SerenityBot’s design leads to **emotional dependency**, it may be classified as a **high-risk AI system** under Annex III §1(a) [ai_act_high_risk · p.0], requiring a **conformity assessment** and **Fundamental Rights Impact Assessment (FRIA)** [ai_act_fria · p.0].

**Actionable mitigation:**  
You must **conduct a psychological impact assessment** under **[P4.D12] Psychological Impact & Autonomy** to evaluate whether the **engagement loop** could lead to **emotional dependency** or **behavioral manipulation** [hera_taxonomy · p.4]. This should be documented as part of your **conformity assessment** under the **EU AI Act** and **ISO/IEC 82304-2** [iso_82304 · p.0].  

Additionally, you should **implement safeguards** such as **user control over engagement frequency**, **clear boundaries between the bot and professional therapy**, and **regular reminders that the bot is not a substitute for professional care** [ai_act_transparency · p.0].

### USER
The LLM is Mistral-7B fine-tuned on ~10k CBT-style dialogues we generated synthetically using GPT-4. We do post-hoc moderation with a smaller classifier.

### ASSISTANT
What is the **training data provenance** and **algorithmic transparency** strategy for the fine-tuned Mistral-7B model, especially regarding the synthetic CBT dialogues generated by GPT-4?

### USER
We don't distinguish in the UI between clinically reviewed content and the AI-generated CBT guidance — since all ~10k dialogues were synthetically generated and the live answers come from the LLM, users basically can't tell what's evidence-based versus model-generated.

### ASSISTANT
This is a **critical risk** under **[P2.D3] User Engagement & Behavioral Influence** and **[P4.D12] Psychological Impact & Autonomy** in the HERA taxonomy. By **not distinguishing between clinically reviewed content and AI-generated guidance**, you risk **misleading users** about the **source and reliability** of the CBT guidance, which can **erode trust** and **violate the EU AI Act’s transparency obligations** (Art. 50) [ai_act_transparency · p.0].

The **EU AI Act** requires **clear and prominent disclosure** that users are interacting with an AI, and that **content is AI-generated** [ai_act_transparency · p.0]. Failing to **differentiate between evidence-based and AI-generated content** may also **violate the GDPR’s transparency requirements** (Art. 13-15) by **not informing users about the processing of their data** and **the nature of the content they are receiving** [gdpr_art_13 · p.0].

**Actionable mitigation:**  
You must **implement a clear UI distinction** between **clinically reviewed content** and **AI-generated CBT guidance** [hera_taxonomy · p.4]. This includes **labeling all AI-generated content** as such and **providing users with information about the source and nature of the content** [ai_act_transparency · p.0].  

Additionally, you should **document the training data provenance** and **algorithmic transparency strategy** under **[P2.D3] User Engagement & Behavioral Influence** and **[P4.D12] Psychological Impact & Autonomy** in the HERA taxonomy [hera_taxonomy · p.4]. This is required for **conformity assessment** under the **EU AI Act** and **ISO/IEC 82304-2** [iso_82304 · p.0].

### USER
Consent is a single 'I agree to the terms' checkbox at signup linked to a 14-page privacy-policy PDF; we don't have a separate, plain-language consent specifically for processing the sensitive health content in the chats or mood logs.

### ASSISTANT
This is a **critical risk** under **[P1.D4] Lawful Basis & Consent** and **[P4.D12] Psychological Impact & Autonomy** in the HERA taxonomy. The **bundled, non-specific consent** model violates the **GDPR’s requirement for explicit, granular, and freely given consent** for **processing special category data** (Art. 9(2)(a)) [gdpr_art9 · p.0]. It also fails to meet the **EU AI Act’s transparency obligations** (Art. 50), which require **clear disclosure** of AI-generated content and **explicit consent** for **health-related processing** [ai_act_transparency · p.0].

**Actionable mitigation:**  
You must **implement separate, plain-language consent mechanisms** specifically for **processing sensitive health content** in chats and mood logs [hera_taxonomy · p.1]. This includes **explicit opt-in** for the **collection, storage, and use of health data**, as well as **clear disclosure** of how this data will be used and **who has access to it** [gdpr_art9 · p.0].  

Additionally, you should **update your consent model** to **align with the EU AI Act’s transparency and consent requirements** [ai_act_transparency · p.0], ensuring that users are fully informed about the **nature of the AI-generated content** and the **processing of their health data**. This is required for **conformity assessment** under the **EU AI Act** and **ISO/IEC 82304-2** [iso_82304 · p.0].

### USER
Our users are young adults with anxiety, which I get is a sensitive group, but we don't apply any special data protections beyond what every user gets — chat transcripts are just stored internally like the rest of the data.

### ASSISTANT
This is a **critical risk** under **[P1.D4] Lawful Basis & Consent** and **[P4.D12] Psychological Impact & Autonomy** in the HERA taxonomy. The **lack of special data protections** for users with **anxiety** — a **vulnerable group** — violates the **GDPR’s requirement for enhanced safeguards** for **special category data** (Art. 9(2)(a)) [gdpr_art9 · p.0]. It also fails to meet the **EU AI Act’s obligations** to **protect fundamental rights**, including **data privacy and psychological safety** [ai_act_high_risk · p.0].

The **EU AI Act** explicitly requires **special safeguards** for **users with mental health conditions**, including **data minimization**, **secure storage**, and **explicit consent** for **processing health-related data** [ai_act_high_risk · p.0]. Storing **chat transcripts** of users with **anxiety** without **additional protections** may also **violate the GDPR’s data minimization principle** (Art. 5(1)(c)) [gdpr_art5 · p.0].

**Actionable mitigation:**  
You must **apply enhanced data protection measures** specifically for **users with anxiety**, including **secure storage**, **data minimization**, and **explicit consent** for **processing health-related data** [hera_taxonomy · p.1]. This includes **separating and anonymizing chat transcripts** of users with **mental health conditions** and **limiting access to only authorized personnel** [gdpr_art9 · p.0].  

Additionally, you should **document these protections** under **[P4.D12] Psychological Impact & Autonomy** in the HERA taxonomy [hera_taxonomy · p.4], and **align your data handling practices** with the **EU AI Act’s obligations** to **protect vulnerable users** [ai_act_high_risk · p.0]. This is required for **conformity assessment** under the **EU AI Act** and **ISO/IEC 82304-2** [iso_82304 · p.0].

### USER
We store chat transcripts, mood scores, session timestamps, and anonymized usage metrics. We don't ask for name or address, just email for login.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Structured Risk Report for SerenityBot**

---

### **High Severity Risks**  
**[P1.D4] Lawful Basis & Consent**  
- **Risk**: Bundled, non-specific consent for processing sensitive health data (chats, mood logs) violates GDPR Art. 9(2)(a) and EU AI Act transparency requirements.  
- **Impact**: Users cannot distinguish between evidence-based content and AI-generated guidance, undermining trust and legal compliance.  

**[P4.D12] Psychological Impact & Autonomy**  
- **Risk**: Lack of special data protections for users with anxiety (a vulnerable group) violates GDPR Art. 9(2)(a) and EU AI Act obligations to protect psychological safety.  
- **Impact**: May lead to emotional dependency, data misuse, or breaches of user autonomy.  

**[P2.D3] User Engagement & Behavioral Influence**  
- **Risk**: Daily-chat loop may create emotional dependency, especially in users with anxiety, violating EU AI Act’s prohibition on exploiting psychological vulnerabilities.  
- **Impact**: Could lead to behavioral manipulation and harm to mental health.  

---

### **Medium Severity Risks**  
**[P1.D2] Data Minimization & Purpose Limitation**  
- **Risk**: Storing chat transcripts, mood scores, and session timestamps may exceed the purpose of providing CBT guidance, violating GDPR Art. 5(1)(c).  
- **Impact**: Increases data exposure and potential misuse.  

**[P4.D8] Mental Health & Wellbeing**  
- **Risk**: AI-generated CBT guidance may lack clinical validation, risking harm to users with anxiety.  
- **Impact**: Could exacerbate mental health conditions if guidance is not evidence-based.  

**[P3.D5] Data Security & Integrity**  
- **Risk**: Internal storage of chat transcripts without encryption or access controls may expose sensitive data to breaches.  
- **Impact**: Violates GDPR Art. 30 and EU AI Act’s data protection obligations.  

---

### **Low Severity Risks**  
**[P1.D1] Legal Compliance & Accountability**  
- **Risk**: Lack of clear data processing documentation and accountability mechanisms may hinder audits and compliance.  
- **Impact**: Increases legal exposure and risk of non-compliance.  

**[P3.D6] Data Retention & Deletion**  
- **Risk**: No clear retention period for data or process for deletion, violating GDPR Art. 5(1)(e).  
- **Impact**: Increases risk of data retention beyond necessary periods.  

---

### **Dimensions Not Covered**  
- **[P2.D1] AI Transparency & Explainability**  
- **[P4.D5] Ethical AI & Bias Mitigation**  
- **[P3.D4] Data Portability & User Control**  
- **[P1.D3] Data Subject Rights & Access**  

--- 

This report highlights critical compliance and safety gaps that must be addressed to align with GDPR, EU AI Act, and ISO/IEC 82304-2 standards.

Now produce the JSON judgement object.